| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $10.3M | -44.9% |
| SG&A Expense | $12.2M | +88.2% |
| Operating Income | -$22.5M | +10.6% |
| Income Tax | $800 | +0.0% |
| Net Income | -$22.2M | +18.5% |
| EPS (Basic) | -$1.06 | +67.5% |
| EPS (Diluted) | -$1.06 | +67.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.2M | +52.3% |
| Current Assets | $13.6M | +48.2% |
| Total Assets | $14.0M | +50.6% |
| Current Liabilities | $5.7M | -35.2% |
| Total Liabilities | $6.1M | -33.7% |
| Stockholders' Equity | $7.9M | +7505.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$19.2M | +12.1% |
| Financing Cash Flow | $23.7M | -13.8% |